verified SJR 1,648 · Q1 • database Scopus / SJR & Web of Science indexed

France · Elsevier Masson s.r.l.

workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Diabetes and Metabolism

Diabetes and Metabolism is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology with an H index of 110. It has an SJR impact factor of 1,648 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,648.

ISSN: 1262-3636

Publisher: Elsevier Masson s.r.l.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,648 Q1

H-index 110

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,648

H-index

110

Docs (year)

Docs 3y

231

Total refs

2155

Cites 3y

926

Citable 3y

178

Cites/Doc 2y

3.8

Ref/Doc

34.21

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Concerns over the consequences of regional disparities for elderly French type 2 diabetes patients in the Gerodiab study

When should screening be performed for gestational diabetes?

FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study

Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: Importance of fasting plasma glucose

Evaluation of the relationship between cardiovascular risk factors and periaortic fat thickness in children with type 1 diabetes mellitus

Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME

Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal

Diagnostic criteria for gestational diabetes mellitus

Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: From one crisis to another

Dental implants and diabetes: Conditions for success

Delivery (timing, route, peripartum glycemic control) in women with gestational diabetes mellitus

Definition, epidemiology, risk factors

SHOW MORE ARTICLES

Current insulin therapy in patients with type 2 diabetes: Results of the ADHOC survey in France

A prospective study of leucocyte mitochondrial DNA content and deletion in association with the metabolic syndrome

Complement activation in patients with diabetic nephropathy

Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes

Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia

Brain, liver, intestine: a triumvirate to coordinate insulin sensitivity of endogenous glucose production

Anthropometric characteristics and cardiometabolic risk factors in a sample of urban-dwelling adults in Senegal

Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies

Adipose tissue and adipocyte dysregulation

Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: Association with insulin resistance and type 2 diabetes

Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities

Acute consequences of hypoglycaemia in diabetic patients

FAQs

Diabetes and Metabolism has an SJR of 1,648 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Diabetes and Metabolism is 25%.

Diabetes and Metabolism

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Diabetes and Metabolism?

What is the APC / publication cost?

What is the acceptance rate?